Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Investments:
Fixed maturity available-for-sale securities, at fair value (amortized cost: 2019 – $92,894; 2018 – $92,429)	$ 98,050	$ 94,024
Trading securities	3,314	1,950
Equity securities	153	99
Mortgage loans on real estate	13,997	13,260
Policy loans	2,498	2,509
Derivative investments	981	1,107
Other investments	2,752	2,267
Total investments	121,745	115,216
Cash and invested cash	1,593	2,345
Deferred acquisition costs and value of business acquired	9,441	10,264
Premiums and fees receivable	607	570
Accrued investment income	1,184	1,119
Reinsurance recoverables	17,660	17,748
Funds withheld reinsurance assets	549	557
Goodwill	1,778	1,782
Other assets	16,373	15,713
Separate account assets	143,369	132,833
Total assets	314,299	298,147
Liabilities
Future contract benefits	34,009	34,648
Other contract holder funds	93,959	91,233
Short-term debt	300
Long-term debt	5,572	5,839
Reinsurance related embedded derivatives	177	3
Funds withheld reinsurance liabilities	1,762	1,740
Payables for collateral on investments	5,362	4,805
Other liabilities	13,372	12,696
Separate account liabilities	143,369	132,833
Total liabilities	297,882	283,797
Contingencies and Commitments (See Note 11)
Stockholders' Equity
Preferred stock - 10,000,000 shares authorized
Common stock – 800,000,000 shares authorized; 202,987,229 and 205,862,760 shares issued and outstanding as of March 31, 2019, and December 31, 2018, respectively	5,285	5,392
Retained earnings	8,679	8,551
Accumulated other comprehensive income (loss)	2,453	407
Total stockholders' equity	16,417	14,350
Total liabilities and stockholders' equity	$ 314,299	$ 298,147